United Therapeutics reported $468M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Amarin USD 36.71M 8M Sep/2025
Ardelyx USD 18.39M 3.29M Sep/2025
Baxter International USD 953M 42M Sep/2025
Bayer EUR 6.38B 343M Sep/2025
Biogen USD 413.1M 4.7M Sep/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.68B 855M Sep/2025
Halozyme Therapeutics USD 15.36M 3.33M Sep/2025
Insmed USD 79.59M 1.24M Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
J&J USD 9.62B 161M Sep/2025
Moderna USD 267M 92M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
PTC Therapeutics USD 36.62M 169.69M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
Teva Pharmaceutical Industries USD 2.53B 176M Dec/2025
United Therapeutics USD 468M 36M Sep/2025
Vertex Pharmaceuticals USD 4.03B 320.8M Sep/2025